SLAM BioTherapeutics, Inc. — Form D
SLAM BioTherapeutics, Inc. of WESTLAKE VILLAGE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-13. The offering totals $20.0M, of which $7.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-13
- Form: D
- Accession: 0001983523-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $7.7M
- Remaining: $12.3M
- Investors: 38
- Date of first sale: 2023-11-03
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-496992
Issuer
- Name: SLAM BioTherapeutics, Inc.
- CIK: 0001983523
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 2945 TOWNSGATE RD., SUITE 200, WESTLAKE VILLAGE, CA, 91361
- Phone: 617-513-4934
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Richard Heinick | Director | Westlake Village, CA |
| Richard Heinick | Executive Officer | Westlake Village, CA |
| Ted Schwartz | Director | Westlake Village, CA |
| Steve Pazol | Director | Westlake Village, CA |
| Mark Hagler | Director | Westlake Village, CA |
| David Vennettilli | Director | Westlake Village, CA |
| Theodore Schwartz | Director | Thousand Oaks, CA |
| Steve Potts | Director | Thousand Oaks, CA |
| Steve Potts | Executive Officer | Thousand Oaks, CA |
Other filings by this issuer (2)
More